The Patient-Centered Outcomes Research Institute is funding the trial; $29.9 million was awarded to Mount Sinai and Weill Cornell Medicine. The study, which will enroll about 1,200 patients at 45 sites across the U.S. and Canada, is set to be conducted in phases and will begin in October.
Many trials comparing procedures including coronary artery bypass graft surgery and percutaneous coronary intervention have focused on white men.
“There is a great need to generate high-quality evidence to guide clinical decision-making for such procedures in women and minority groups who have been underrepresented in most prior studies,” said Gregg Stone, MD, director of academic affairs for the Mount Sinai Health System and cardiology professor of medicine and population health science and policy at the medical school.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
